D, O., E, C., P, W., A, E., M, A., U, P., . . . P, F. (2026). Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis. Frontiers in psychiatry, 17, 1823912. https://doi.org/10.3389/fpsyt.2026.1823912
Chicago Style (17th ed.) CitationD, Oliver, et al. "Acceptability of Cannabidiol as a Treatment for People at Clinical High Risk for Psychosis." Frontiers in Psychiatry 17 (2026): 1823912. https://doi.org/10.3389/fpsyt.2026.1823912.
MLA (9th ed.) CitationD, Oliver, et al. "Acceptability of Cannabidiol as a Treatment for People at Clinical High Risk for Psychosis." Frontiers in Psychiatry, vol. 17, 2026, p. 1823912, https://doi.org/10.3389/fpsyt.2026.1823912.
Warning: These citations may not always be 100% accurate.